EXPERIENCES WITH ACE-INHIBITORS EARLY AFTER ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE GERMAN-MULTICENTER-STUDY ON THE EFFECTS OF CAPTOPRIL ON CARDIOPULMONARY EXERCISE PARAMETERS POST MYOCARDIAL-INFARCTION (ECCE)
Fx. Kleber et al., EXPERIENCES WITH ACE-INHIBITORS EARLY AFTER ACUTE MYOCARDIAL-INFARCTION - RATIONALE AND DESIGN OF THE GERMAN-MULTICENTER-STUDY ON THE EFFECTS OF CAPTOPRIL ON CARDIOPULMONARY EXERCISE PARAMETERS POST MYOCARDIAL-INFARCTION (ECCE), Herz, 18, 1993, pp. 424-429
Left ventricular damage by necrosis of myocardial tissue can lead to c
ompromise of left ventricular function, to left ventricular volume inc
rease and ultimately to development of heart failure. This sequence in
the pathophysiology has been shown to be blunted by ace inhibitors. V
olume increase, however, can also be helpful in restoring stroke volum
e and ameliorate elevation of filling pressures. Furthermore, very ear
ly institution of ACE inhibition has failed to improve short-term mort
ality after myocardial infarction in one large trial. The aim of ECCE
trial therefore is, to investigate the early effects of the ACE inhibi
tor captopril on compromise of exercise capacity, thought to be a firs
t measurable sign of developing heart failure. The ECCE trial is a ran
domized, seven-center investigation, studying the effects of ACE inhib
ition on oxygen uptake in a double blind, placebo controlled design in
a group of 204 patients. Sample size was calculated on the basis of a
pilot trial. The study design and first not unblinded data of 104 pat
ients are presented. The population consists of predominantly male pat
ients with mostly first myocardial infarction. They were admitted to h
ospital within five hours of onset of chest pain. Enddiastolic volumes
were normal, but ejection fraction was moderately compromised. ACE in
hibition was started after the first day, but within 72 hours of onset
of chest pain. After four and after twelve weeks, oxygen uptake was c
onsiderably below expected values and one third of the patients had se
vere compromise of exercise capacity. Thus the patients recruited in t
he ECCE trial are at risk for developing heart failure and therefore a
re ideal candidates for the study of the preventive effects of ACE inh
ibitors. Final results will be available in early 1994.